Drugs that contain Eliglustat Tartrate

1. List of Cerdelga drug patents

CERDELGA's oppositions filed in EPO
CERDELGA Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6916802 GENZYME CORP Amino ceramide-like compounds and therapeutic methods of use
Apr, 2022

(1 year, 30 days ago)

US7196205 GENZYME CORP Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
Jun, 2026

(3 years from now)

US11458119 GENZYME CORP Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
Nov, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615573 GENZYME CORP Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
Apr, 2022

(1 year, 30 days ago)

US7253185 GENZYME CORP Amino ceramide-like compounds and therapeutic methods of use
Apr, 2022

(1 year, 30 days ago)

US10888547 GENZYME CORP Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
Jan, 2031

(7 years from now)

US10888544 GENZYME CORP Methods for treating Gaucher disease
Dec, 2038

(15 years from now)

Do you want to check out CERDELGA patents from before 2022?

Market Authorisation Date: 19 August, 2014

Treatment: Treatment of gaucher disease type 1; Long-term treatment of adults with gaucher disease type 1 who are cyp2d6 poor metabolizers with 84 mg once daily of eliglustat (equivalent to 100 mg of eliglustat ...

Dosage: CAPSULE;ORAL

How can I launch a generic of CERDELGA before it's patent expiration?
More Information on Dosage

CERDELGA family patents

44

United States

13

Japan

12

European Union

7

Spain

7

Canada

7

Portugal

6

Denmark

6

China

6

Brazil

6

Korea, Republic of

6

Cyprus

5

Australia

4

Hong Kong

4

Poland

4

Israel

3

RS

3

Singapore

3

Argentina

EA

3

EA

3

New Zealand

3

Croatia

3

Taiwan

3

Mexico

3

Slovenia

2

Austria

2

Dominican Republic

2

Peru

2

Chile

2

Ecuador

2

Lithuania

2

Hungary

1

Philippines

1

Malaysia

1

Russia

1

Ukraine

1

Morocco

1

ME

1

Nicaragua

1

San Marino

1

Belgium

1

Guatemala

1

Costa Rica

1

Colombia

1

Luxembourg

1

Tunisia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in